Literature DB >> 15196229

Deprivation, comorbidity and survival in a cohort of patients with colorectal cancer.

A J Munro1, A H M Bentley.   

Abstract

We studied a regionally based cohort of 483 consecutive patients with colorectal cancer referred for chemotherapy and/or radiotherapy. These patients were assessed and managed according to consistent policies. We investigated the effects of socio-economic deprivation and comorbidity upon survival. Significant comorbidity was present in 48% of the patients. Overall survival and cause-specific survival were summarized using Kaplan-Meier curves. Equality of survivor functions was assessed using the logrank procedure and Cox's proportional hazards analysis. In univariate analysis, the following variables significantly affected survival: comorbidity, performance status, age and clinical stage. We could find no correlation between deprivation and comorbidity. The presence of comorbidity significantly affected cause-specific survival (3-year cause-specific survival without comorbidity 54.2%; with comorbidity 44.6%). In adjusted analysis, deprivation had an independently adverse effect on overall survival, hazard ratio 1.04 (95% confidence interval 1.00-1.08), but this was only of borderline statistical significance, P = 0.049. This study demonstrates that the interrelationships between comorbidity, deprivation and outcome in this group of patients are complex: even when care is readily available, patient assessments are uniform, and clinical decision making is consistent.

Entities:  

Mesh:

Year:  2004        PMID: 15196229     DOI: 10.1111/j.1365-2354.2004.00480.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  8 in total

1.  Radiosensitivity of human colon cancer cell enhanced by immunoliposomal docetaxel.

Authors:  Qing-Wei Wang; Hui-Lan Lu; Chang-Cheng Song; Hong Liu; Cong-Gao Xu
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

2.  Access to care and outcomes for neuroendocrine tumours: does socioeconomic status matter?

Authors:  J Hallet; N G Coburn; S Singh; K Beyfuss; S Koujanian; N Liu; C H L Law
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

3.  Bone marrow transplantation in AML, and socioeconomic class: a UK population-based cohort study.

Authors:  Fatima Bhayat; Emma Das-Gupta; Richard Hubbard
Journal:  BMC Cancer       Date:  2010-09-28       Impact factor: 4.430

4.  The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study.

Authors:  Diana Sarfati; Sarah Hill; Tony Blakely; Bridget Robson; Gordon Purdie; Elizabeth Dennett; Donna Cormack; Kevin Dew
Journal:  BMC Cancer       Date:  2009-04-20       Impact factor: 4.430

5.  Advanced stage presentation and its determinant factors among colorectal cancer patients in Amhara regional state Referral Hospitals, Northwest Ethiopia.

Authors:  Mulugeta Wassie; Debrework Tesgera Beshah; Yenework Mulu Tiruneh
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

6.  Palliative chemotherapy in carcinoma penis: Does platinum and taxane combination holds a promise?

Authors:  Vijay M Patil; Vanita Noronha; Amit Joshi; Vamshi Muddu; Bharat Bhosale; Ganesh Bakshi; Kumar Prabhash
Journal:  Urol Ann       Date:  2014-01

7.  Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network.

Authors:  Lucía Cea Soriano; Montse Soriano-Gabarró; Luis A García Rodríguez
Journal:  BMC Cancer       Date:  2018-04-10       Impact factor: 4.430

8.  Improving management of comorbidity in patients with colorectal cancer using comprehensive medical assessment: a pilot study.

Authors:  Virginia Signal; Christopher Jackson; Louise Signal; Claire Hardie; Kirsten Holst; Marie McLaughlin; Courtney Steele; Diana Sarfati
Journal:  BMC Cancer       Date:  2020-01-20       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.